Candyce Kroenke to Chemotherapy, Adjuvant
This is a "connection" page, showing publications Candyce Kroenke has written about Chemotherapy, Adjuvant.
Connection Strength
0.842
-
Social Support and Treatment Delays in Breast Cancer Patients Within an Integrated Health Care System. Psychooncology. 2024 Nov; 33(11):e70025.
Score: 0.215
-
Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Breast Cancer Res Treat. 2018 Aug; 170(3):623-631.
Score: 0.137
-
Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast?cancer. J Natl Cancer Inst. 2026 Jul 01; 118(7):1278-1289.
Score: 0.060
-
The landscape of chemotherapy modifications among women treated for stage I-IIIA breast cancer. Cancer. 2026 Mar 15; 132(6):e70318.
Score: 0.059
-
Initial chemotherapy dose reductions and subsequent treatment delivery in stage I-IIIA breast cancer. Cancer. 2026 Mar 01; 132(5):e70294.
Score: 0.059
-
Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer. J Natl Cancer Inst. 2026 Feb 01; 118(2):307-315.
Score: 0.059
-
Evaluation of methods to identify chemotherapy-related hematologic toxicities in real-world settings. Int J Cancer. 2026 Mar 15; 158(6):1481-1488.
Score: 0.058
-
Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I-IIIA breast cancer. Breast Cancer Res Treat. 2025 Aug; 213(1):115-126.
Score: 0.056
-
Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study. JCO Clin Cancer Inform. 2025 Feb; 9:e2400231.
Score: 0.055
-
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019. Breast Cancer Res. 2024 Jun 13; 26(1):101.
Score: 0.052
-
Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study. Cancer. 2017 Dec 15; 123(24):4868-4877.
Score: 0.033